Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin60.7%+1.3pp59.3%+2.1pp57.2%+0.5pp56.7%-1.0pp57.7%-2.1pp
Operating margin23.7%+0.7pp23%+2.3pp20.7%+2.4pp18.4%-3.0pp21.4%-5.5pp
Net margin9.4%+1.4pp8.1%+0.3pp7.7%+2.6pp5.1%-1.5pp6.6%-4.3pp
Returns
Return on equity27.4%+3.7pp23.7%+0.7pp23%+6.8pp16.2%-3.1pp19.2%-13.4pp
Return on invested capital172.1%+46.5pp125.6%
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.5×-0.1×0.5×+0.1×0.5×0.0×
Liquidity
Current ratio1.7×+0.1×1.6×+0.2×1.4×+0.2×1.2×+0.1×1.1×+0.1×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Net debt / EBITDA-1.1×-0.1×-1×-0.5×-0.5×-0.1×-0.4×-0.1×-0.3×-0.1×
Per Share
Book value per share$7.80+3.6%$7.53+8.0%$6.97+17.3%$5.94-16.8%$7.14+25.1%
Valuation
Market capitalization$1.15B+17.9%$1.46B+32.8%$1.1B+13.9%$967.8M+0.9%$959.13M+3.8%
Price / earnings15.4×-6.9×23.3×+4.4×18.9×-7.8×26.7×+4.8×21.9×+8.5×
Price / sales1.5×0.0×1.9×+0.4×1.5×+0.1×1.4×-0.1×1.4×0.0×
Price / book3.6×-0.5×4.9×+0.8×-0.2×4.2×+0.1×4.1×+0.1×
EV / EBITDA3.4×+0.9×5.1×+1.6×3.5×+0.5×+0.4×2.6×+0.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Collegium Pharmaceutical, Inc.'s profit margins?
Collegium Pharmaceutical, Inc. (COLL) runs a 60.7% gross margin and a 23.7% operating margin, with a 9.4% net margin.
Where do Collegium Pharmaceutical, Inc.'s ratios come from?
Every ratio is computed from Collegium Pharmaceutical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.